T
TScan Therapeutics Inc
NASDAQ:TCRX
TScan Therapeutics Inc
NASDAQ:TCRX
Price:
1.04
USD
2.97%
Market Cap:
$59m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
US |
|
Yapi ve Kredi Bankasi AS
IST:YKBNK.E
|
TR |
|
Z
|
Zodiac Energy Ltd
NSE:ZODIAC
|
IN |
|
S
|
Stella International Holdings Ltd
HKEX:1836
|
HK |
|
Carpenter Technology Corp
NYSE:CRS
|
US |
|
GNI Group Ltd
TSE:2160
|
JP |
|
Hithink RoyalFlush Information Network Co Ltd
SZSE:300033
|
CN |
|
China High Speed Transmission Equipment Group Co Ltd
HKEX:658
|
HK |
|
B
|
Beigene Ltd
NASDAQ:BGNE
|
CN |
|
JBM Auto Ltd
NSE:JBMA
|
IN |
|
Daegu Department Store Co Ltd
KRX:006370
|
KR |
|
Jig-Saw Inc
TSE:3914
|
JP |
|
United Tractors Tbk PT
IDX:UNTR
|
ID |
|
Nakanishi Inc
TSE:7716
|
JP |
|
H
|
HPP Holdings Bhd
KLSE:HPPHB
|
MY |
|
S
|
Suntech SA
WSE:SUN
|
PL |
|
Geomatec Co Ltd
TSE:6907
|
JP |
|
Tianfeng Securities Co Ltd
SSE:601162
|
CN |
|
Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
|
CN |
|
Xiangpiaopiao Food Co Ltd
SSE:603711
|
CN |
Multiples-Based Value
The Multiples-Based Value for TScan Therapeutics Inc (TCRX) under the Base Case is hidden USD. Compared with the current market price of 1.04 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TCRX Multiples-Based Value
LOCKED
Multiples Across Competitors
TCRX Competitors Multiples
TScan Therapeutics Inc Competitors
TScan Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
59.2m USD | 5.7 | -0.5 | 0.5 | 0.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 5.8 | 85.3 | 14.2 | 19.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 4.9 | 23.6 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9 | 27.4 | 20.5 | 21.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
